Synapsoft logo
AI Insights from Disclosures
Searching...
Pharmicell Co.,Ltd. 005690
Searching...

Company Summary

Quarterly Performance Revenue Operating Margin

Market Sentiment

※ Click the graph to view AI analysis information for that month.
Revenue
Consolidated
Separate
Operating Income
Consolidated
Separate
Net Income
Consolidated
Separate

Financials

Excel

No financial data is available for this period.
~
Quarterly
Annual
No data is available for this period.

*Values beyond the fourth decimal place of the unit are displayed as '0/-0'

Financial Indicator Forecast

※ These forecasts are simple AI estimates based on historical data and may differ from actual results.

Company Overview

as of June 2026
Pharmicell Co.,Ltd. is a biopharmaceutical company that developed the world's first stem cell therapy (Hearticellgram-AMI) and operates through two divisions: the Biomedical division and the Biochemical division. The Biomedical division's core business is the development of stem cell therapies; it also runs an adult stem cell banking business based on the know-how accumulated during therapy development, and applies its stem cell culture technology to develop and sell cosmetics containing stem cell culture extract.
Representative Director Kim Hyeonsu
Founded August 20, 1968
Corporation Type KOSPI
Industry Classification Manufacture of electronic components
Corporate number 16011-0005177
Business number 314-81-00664
Phone Number 02-3496-0114
Fax Number 02-3496-0149
Company Address 874 Eonju-ro, Gangnam-gu, Seoul
Products & Services

Financial Health

Executives

Employees

Shareholders

Industry revenue

Disclosures

Comments

0 / 255

AI Assistant